文献速递头颈外科

GHRL基因调控区多态性(-2531C>T)或可预测头颈癌放疗相关口腔黏膜炎

Polymorphism of regulatory region of GHRL gene (-2531C>T) as a promising predictive factor for radiotherapy-induced oral mucositis in patients with head neck cancer.
PubMed 文献 · Head Neck · 2018-03-22

本研究纳入65例接受放疗的头颈癌患者,按RTOG/EORTC量表评估口腔黏膜炎,采用SNaPshot PCR检测GHRL基因c.-2531C>T(rs1629816)基因型。

要点

  • GHRL c.-2531C>T AA基因型与放疗第6周2–3级口腔黏膜炎风险降低相关。
  • 各基因型间口腔V30、V40、V50未见统计学显著差异。

核心结论

  • GHRL基因c.-2531C>T(rs1629816)AA基因型与头颈癌放疗患者发生更严重口腔黏膜炎的风险相关。

研究设计与样本

  • 研究纳入65例接受放疗的头颈癌患者。
  • 口腔黏膜炎按RTOG/EORTC量表评估。
  • 自全血提取DNA,采用minisequencing法(SNaPshot PCR)确定基因型。

主要发现

  • 基因型频率:AA 21.5%;GA 40%;GG 38.5%。
  • 不同GHRL基因型间口腔勾画体积V30、V40、V50无统计学显著差异。

关键数值与推荐

  • AA基因型者放疗第6周发生2–3级口腔黏膜炎风险降低约7倍(原文表述)。
  • 口腔黏膜炎严重程度按RTOG/EORTC量表分级。
  • 基因型检测方法为SNaPshot PCR。

临床怎么用

  • 可考虑检测GHRL c.-2531C>T基因型辅助识别放疗期间口腔黏膜炎高风险患者。
  • 对非AA基因型患者加强口腔黏膜炎监测与预防。
  • 结果需更大样本验证后再用于临床决策。

局限性

  • 样本量仅65例。
  • 单中心研究,结论外推需谨慎。
  • 口腔剂量学参数V30、V40、V50与基因型未见显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to investigate the relationship between single nucleotide polymorphisms (SNP; rs1629816) in the regulatory region (c.-2531C>T) of the ghrelin (GHRL) gene and the occurrence and severity of oral mucositis caused by radiotherapy (RT) in patients with head and neck cancer. METHODS: Oral mucositis in 65 patients with head and neck cancer who underwent irradiation were assessed according to Radiation Therapy Oncology Group (RTOG)/European Organisation for Research and Treatment of Cancer (EORTC) scale. The DNA from patients with head and neck cancer was isolated from whole blood. The genotypes were determined using the minisequencing method (SNaPshot PCR). RESULTS: The frequency of occurrence of the GHRL gene (c.-2531C>T, rs1629816) genotypes were as follows: AA = 21.5%; GA = 40%; and GG = 38.5%. In case of AA genotype, there was a 7-fold decrease of the risk of occurrence of oral mucositis (of grades 2 and 3) in the sixth week of RT (AA vs GA or GG, respectively: 17.9% vs 82.1% patients; odds ratio [OR] 0.14; 95% confidence interval [CI] 0.02-0.98; P = .0481). No statistically significant differences were observed between the volume of oral cavity contours (V30, V40, and V50) depending on the GHRL genotype in patients with head and neck cancer. CONCLUSION: The study results have demonstrated an association between the AA genotype of the GHRL gene and the risk of more severe oral mucositis attributed to RT in patients with head and neck cancer.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Brzozowska A, Homa-Mlak I, Mlak R, et al. Polymorphism of regulatory region of GHRL gene (-2531C>T) as a promising predictive factor for radiotherapy-induced oral mucositis in patients with head neck cancer. Head Neck. 2018. PMID: 29566446. doi:10.1002/hed.25154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。